Journey Clinical Company Research Report

Company Overview

• Name: Journey Clinical, Inc.

• Mission of the Company: To expand access to psychedelic-assisted psychotherapy safely and responsibly by empowering licensed mental health professionals. Journey Clinical aims to transform mental health through innovative treatments like Ketamine-Assisted Psychotherapy (KAP) by providing a collaborative care model that includes therapists, medical professionals, and comprehensive resources.

• Founded: Founded by Jonathan Sabbagh and Myriam Barthes in 2020.

• Key People:

• Jonathan Sabbagh: Co-Founder & CEO

• Myriam Barthes: Co-Founder & COO

• Dr. Kyle Lapidus, MD, PhD: Medical Director

• Headquarters: No specific location for headquarters stated.

• Number of Employees: No information is available.

• Revenue: No information is available.

• Known For: Journey Clinical is known for being the leading telehealth platform that provides access to Ketamine-Assisted Psychotherapy (KAP) through a collaborative care model. It is noted for having the largest network of KAP providers in the US and focuses on improving clinical outcomes in mental health treatment.

Products

Ketamine-Assisted Psychotherapy (KAP)

• High-Level Description: A holistic psychedelic-assisted modality combining ketamine treatment with psychotherapy sessions designed to achieve deeper therapeutic breakthroughs and improve mental health outcomes for conditions like depression and anxiety.

• Key Features:

• Collaborative Care Model: Integrates a dedicated medical team and licensed psychotherapists to create personalized treatment plans.

• Comprehensive Offerings: Includes aspects of screening, prescriptions, outcome monitoring, and psychiatric medication management.

• Flexible Modalities: Supports various KAP protocols such as in-person, remote, group, and self-led sessions to provide flexibility based on patient needs.

• Therapist Support: Offers CE credits, peer consultation, access to a robust library of educational resources, and community support for therapists.

• Eligibility: Determined by Journey Clinical’s in-house medical team, with treatments provided to patients over the age of 18 in selected states.

Recent Developments

• New Products Launched: Integration of comprehensive psychiatric medication management alongside KAP to provide holistic mental health treatment.

• Recent Partnerships: Collaboration with COMPASS Pathways to research psilocybin treatment delivery.

• New Features Added: Expanded services including group KAP protocols, couples therapy, and additional modalities such as EMDR, Couples Therapy, and IFS within the psychotherapy offerings.

• Network Expansion: As of 2023, Journey Clinical expanded to include over 800 therapists in its network, reaching thousands of patients and facilitating several thousand KAP sessions to date.

Additional Information

• Care Model: Journey Clinical highlights its commitment to patient safety and wellbeing through its patient-centered collaborative care model; aims to democratize access to psychotherapy by enabling licensed therapists through streamlined telehealth services.

• Geographical Availability: Services are open to patients and therapists in 20 US states, including California, New York, Massachusetts, and Washington among others.

Note: The above report is based on the information available from the provided data set. Some fields may contain "No information is available" due to the lack of specific details in the source data.